AMS 700 Inflatable Penile Prosthesis (IPP) with and without InhibiZone
Boston Scientific Corp · Decision date May 18, 2026
What did the FDA approve?
FDA records N970012/S211 as a supplement to PMA null, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 18, 2026.
FDA approval order statement
Approval for the design change to the TENACIO pump control valve.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- May 18, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- N970012/S211
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- Decision code
- APPR
- Decision date
- May 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, penis, inflatable.
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
N970012/S211 received
Application receipt date recorded by FDA.
N970012/S211 · FDA decision
Real-Time Process
Related devices and submissions
Explore the linked device profile
Other records with product code JCW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AMS 700 Inflatable Penile Prosthesis (IPP)N970012/S212 | Boston Scientific Corp | PMA supplement | Sep 14, 2026 | FDA |
| Boston Scientific Corp | PMA supplement | Oct 2, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 100 Boston Scientific Way, Marlboro, MA, 01752
Sources and methodology
- Original FDA record: N970012/S211
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
